Health X Platform CEO, MD, chairman, board of directors and AGM
NSE: HEALTHXBSE: 533259Healthcare ServicesSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹268.85.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹849 Cr1,526th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 1.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- −3.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- −9.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 7,88571.6% delivered
Health X Platform board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing director and CEOBanwari Lal Mittal
- Company Secretary and Compliance OfficerPratap Singh
6 directors3 independent1 executive2 non-executive
- Banwari Lal Mittal · Chairperson and managing director and CEOExecutive · joined May 2005 · reappointed Jul 2023 · 1 listed board · 1 committee seat
- Ravi Kant SharmaNon-executive · joined May 2005 · reappointed May 2005 · 1 listed board · 3 committee seats
- Abha MittalNon-executive · joined Mar 2015 · reappointed Mar 2015 · 1 listed board
- Rupanjana DeIndependent · joined Sep 2020 · reappointed Sep 2025 · 69 months as independent · 3 listed boards · 3 as independent · 9 committee seats, 1 as chair
- Jayanta Nath MukhopadhyayaIndependent · joined Jun 2021 · reappointed Jun 2024 · 24 months as independent · 1 listed board · 1 as independent · 3 committee seats, 2 as chair
- Anjana DikshitIndependent · joined Nov 2023 · reappointed Nov 2023 · 31 months as independent · 2 listed boards · 2 as independent · 3 committee seats, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 10 Jun 20266 of 6 present3 independent · 10 days in between
- 30 May 20266 of 6 present3 independent · 91 days in between
- 27 Feb 20266 of 6 present3 independent · no day in between
- 26 Feb 20266 of 6 present3 independent · 19 days in between
2 earlier meetings
- 6 Feb 20266 of 6 present3 independent · 29 days in between
- 7 Jan 20266 of 6 present3 independent
Audit Committee
Chair Rupanjana De
Ravi Kant Sharma, Jayanta Nath Mukhopadhyaya, Anjana Dikshit
- 10 Jun 20264 of 4 present3 independent · 10 days in between
- 30 May 20264 of 4 present3 independent · 112 days in between
- 6 Feb 20264 of 4 present3 independent
Nomination and remuneration committee
Chair Anjana Dikshit
Ravi Kant Sharma, Rupanjana De, Jayanta Nath Mukhopadhyaya
- 30 May 20264 of 4 present3 independent · 112 days in between
- 6 Feb 20264 of 4 present3 independent
Stakeholders Relationship Committee
Chair Jayanta Nath Mukhopadhyaya
Banwari Lal Mittal, Rupanjana De, Anjana Dikshit
- 30 May 20264 of 4 present3 independent · 112 days in between
- 6 Feb 20264 of 4 present3 independent
Risk Management Committee
Chair Banwari Lal Mittal
Ravi Kant Sharma, Rupanjana De
- 30 May 20263 of 3 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- J K V S & COPeer-review certificate valid to Nov 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Health X Platform AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Health X Platform dividend history
Annual general meeting, 28 Sep 2026
11,691 shareholders on the register on 21 Sep 2026; present: 10 promoters and 94 others; votes counted by RAJ KUMAR BANTHIA / MKB & ASSOCIATES.The company's voting result (opens in a new tab)
To receive, consider and adopt the Audited Financial Statements (both Standalone and Consolidated) of the Company for the financial year ended 31st March, 2026, together with Report of the Board of Directors and Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 78.84% · promoters 100.00% · institutions 63.06% · other public 7.96%
- To appoint a Director in place of Mrs. Abha Mittal (DIN: 00519777) who retires by rotation, and being eligible offers herself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 78.84% · promoters 100.00% · institutions 63.06% · other public 7.96%
- Re-appointment of Mrs. Anjana Dikshit (DIN - 10377490) as an Independent Director of the Company for the second term of 5 (five) consecutive years i.e., from November 10, 2026 upto November 9, 2031.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 78.84% · promoters 100.00% · institutions 63.06% · other public 7.96%
- To approve the overall borrowing limit of the Company under Section 180(1)(c) of the Companies Act, 2013.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 78.84% · promoters 100.00% · institutions 63.06% · other public 7.96%
- To seek approval under Section 180(1)(a) of the Companies Act, 2013 inter-alia for creation of mortgage or charge on the assets, properties or undertaking(s) of the Company.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 78.84% · promoters 100.00% · institutions 63.06% · other public 7.96%
- To seek approval for authorising loans, guarantees, security and making investments in Securities pursuant to Section 186 of the Companies Act, 2013.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 78.84% · promoters 100.00% · institutions 63.06% · other public 7.96%
- To approve for advance any loan/ give guarantee/ provide security under Section 185 of the Companies Act, 2013.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 78.84% · promoters 100.00% · institutions 63.06% · other public 7.96%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.
Mutual fund votes, meeting of 13 Feb 2026, 2 fund houses
- To consider and approve the amendments in Main Object Clause of Memorandum of Association of the Company.2 for0 against
To consider and approve the change in name of the Company from Sastasundar Ventures Limited to Health X Platform Limited and consequential amendment to the Memorandum and Articles of Association of the Company.MoreLess
2 for0 against
Mutual fund votes, meeting of 26 Sep 2025, 2 fund houses
- To appoint a Director in place of Mr. Ravi Kant Sharma (DIN: 00364066), who retires by rotation, and being eligible offers himself for re-appointment.
Against Bandhan Mutual Fund
- Bandhan Mutual FundRavi Kant Sharma, 50, is one of the promoters and founders of the company which was previously named as Microsec Financial Services Limited in 2000. He has more than 20 years of experience in financial services and managing Healthcare platforms. He has attended all four board meetings in FY25. We note that Ravi Kant Sharma is a member of the Audit Committee since February 2007. The statutory auditors have qualified the internal financial controls because as per the auditors of Sastasundar Healthbuddy Limited: material subsidiary, it has weaknesses in its receivable’s reconciliation process with logistics partners. This may result in potential non-recovery of dues or misstatement of balances. We believe the audit committee of Sasta Sundar Ventures bears responsibility and must address the statutory auditor’s concerns of the material subsidiary which accounts for ~99% of the consolidated revenue from operation. Therefore, we do not support the resolution.
1 for1 against To appoint M/s MKB and Associates, Practicing Company Secretaries (Firm Registration No. P2010WB042700 as the Secretarial Auditors of the Company for a term of five consecutive financial years from FY 2025-26 to FY 2029-30 and remuneration.MoreLess
2 for0 againstTo receive, consider and adopt the Audited Financial Statements (both Standalone and Consolidated) of the Company for the financial year ended 31st March, 2025, together with Report of the Board of Directors and Auditors thereon.MoreLess
Against Bandhan Mutual Fund
- Bandhan Mutual FundWe have relied on the auditor’s report which has qualified the internal financial controls on account of material weakness reported by the auditors of Sastasundar Healthbuddy Limited: subsidiary company. As per the subsidiary’s auditors, Sastasundar Healthbuddy Limited, has weaknesses in its receivable reconciliation process with logistics partners. This may result in potential non-recovery of dues or misstatement of balances. The auditors of the company also raise an emphasis of matter with respect to Material Uncertainty Relating to Going Concern of Genu Path Labs Limited (GPLL), a step-down subsidiary. The auditors of GPLL through their audit report state that GPLL’s current liability exceeds its current assets as at 31 March 2025 and as of that date the Company’s net worth has been eroded. Given the internal financial controls are qualified, we do not support the resolution.
1 for1 against
6 earlier meetings
Mutual fund votes, meeting of 18 Aug 2025, 2 fund houses
Re-appointment of Mrs. Rupanjana De (DIN - 01560140) as an Independent Director, not liable to retire by rotation, to hold office for a second term of five consecutive years i.e., from September 15, 2025 upto September 14, 2030.MoreLess
2 for0 against
Mutual fund votes, meeting of 30 Sep 2024, 2 fund houses
- To appoint a Director in place of Mrs. Abha Mittal (DIN: 00519777) who retires by rotation, and being eligible offers herself for re-appointment.2 for0 against
To receive, consider and adopt the Audited Financial Statements (both Standalone and Consolidated) of the Company for the financial year ended 31st March, 2024 together with Report of the Board of Directors and Auditors thereon.MoreLess
2 for0 against
Mutual fund votes, meeting of 25 Mar 2024, 1 fund house
Approval of Material Related Party Transaction(s) between Sastasundar Healthbuddy Limited, subsidiary of Sastasundar Ventures Limited and Retailer Shakti Supply Chain Private Limited, step down subsidiary of Sastasundar Ventures Limited, for an aggregate value of upto Rs.600 crore, for each Financial Year from Financial Year 2023-24.MoreLess
1 for0 against
Mutual fund votes, meeting of 30 Jan 2024, 1 fund house
Appointment of Mrs. Anjana Dikshit (DIN - 10377490) as an Independent Director, not liable to retire by rotation, to hold office for a term of three consecutive years i.e., from 10th November, 2023 upto 9th November, 2026.MoreLess
1 for0 againstRe-appointment of Dr. Jayanta Nath Mukhopadhyaya (DIN - 09015844) as an Independent Director, not liable to retire by rotation, to hold office for a second term of five consecutive years i.e., from 22nd June, 2024 upto 21st June, 2029.MoreLess
1 for0 against
Mutual fund votes, meeting of 29 Sep 2023, 1 fund house
Re-appointment of Mr. Banwari Lal Mittal (DIN: 00365809) as Managing Director & CEO of the Company for a further period of five years with effect from 1st July, 2023 to 30th June, 2028 without any remuneration.MoreLess
1 for0 against- To appoint a Director in place of Mr. Ravi Kant Sharma (DIN: 00364066) who retires by rotation, and being eligible offers himself for re-appointment.1 for0 against
To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March, 2023 (both Standalone and Consolidated), together with Report of the Board of Directors and Auditors thereon.MoreLess
1 for0 against
Mutual fund votes, meeting of 29 Sep 2022, 1 fund house
Appointment of M/s. J K V S & Co., Chartered Accountants (FRN 318086E) as Statutory Auditors of the Company who shall hold office for the first term for a period of 5 consecutive years, from the conclusion of this 33rd Annual General Meeting till the conclusion of 38th Annual General Meeting of the Company to be held in the year 2027, at a remuneration.MoreLess
1 for0 againstMaterial Related Party Transaction(s) between Sastasundar Healthbuddy Limited, subsidiary of Sastasundar Ventures Limited and Retailer Shakti Supply Chain Private Limited, step down subsidiary of Sastasundar Ventures Limited for an aggregate value of Upto Rs. 300 crore (provided however such wholesale trade shall not exceed 25% of the total turnover of SHBL in a financial year).MoreLess
1 for0 against- To appoint a Director in place of Mrs. Abha Mittal (DIN: 00519777) who retires by rotation, and being eligible offers herself for re-appointment.1 for0 against
To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March, 2022 (both Standalone and Consolidated), together with Report of the Board of Directors and Auditors thereon.MoreLess
1 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Tax disputes
Reported in the filing for the quarter to Jun 2026.
- Tax disputeThe Commissioner of Service Tax, KolkataSince 23 Jun 2014The matter is pending before the CESTAT.
At the filing before: The Company has filed an appeal against the order passed by Commissioner of Service Tax demanding Rs. 65,19,360/- alleging contravention of the provisions of the Finance Act, 1994 and non-payment of service tax, education cess and H.E. Cess., before CESTAT on 23.06.2014. The hearing was scheduled on 29.01.2025 and then rescheduled to 10.03.2025. The hearing date was further extended to 21.05.2025, where they asked for certain documents. The hearing was scheduled on 05.06.2025; 23.07.2025, 15.09.2025, 08.12.2025, 12.03.2026 and then rescheduled to 15.06.2026.MoreLess
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.